Funding Innovations and the Venture Capital Dilemma

This chapter explores Isomorphic Labs' recent $600 million funding success in AI drug discovery, while critically analyzing venture capital practices that prioritize financial returns over innovation. It argues for government intervention to foster supportive environments for technology sectors, like housing and AI. The chapter also touches on competitive dynamics in satellite technology, SpaceX's ambitious missions, and Intel's strategic shifts under its new CEO amidst industry challenges.